Two new triterpenes, have been isolated from the weed Anagallis arvensis. Their structures, strictly related to that of an oleanane metabolite previously isolated from the same source, have been established on the basis of spectral analyses and chemical correlation with camelliagenin C, a triterpene from Camellia sp.
Polynucleotide binding complexes comprising sterols and saponin
申请人:Nordic Vaccine Technology A/S
公开号:EP2011517A1
公开(公告)日:2009-01-07
The present invention pertains to complexes comprising sterols and saponins. The complexes are capable of binding a genetic determinant including a polynucleotide. The complexes may further comprise a lipophilic moiety, optionally a lipophilic moiety comprising a contacting group and/or a targeting ligand, and/or a saccharide moiety. The complexes may further comprise an immunogenic determinant and/or an antigenic determinant and/or a medicament and/or a diagnostic compound. The complexes may in even further embodiments be encapsulated by an encapsulation agent including a biodegradable microsphere. The present invention also pertains to pharmaceutical compositions and methods of treatment of an individual by therapy and/or surgery, methods of cosmetic treatment, and diagnostic methods practised on the human or animal body.
POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS
申请人:Nordic Vaccine Technology A/S
公开号:EP1377320B1
公开(公告)日:2008-10-01
THERAPEUTICAL VACCINATION
申请人:Nordic Vaccine Technology A/S
公开号:EP1409009A1
公开(公告)日:2004-04-21
PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS
申请人:DALSGAARD Kristian
公开号:US20110020226A1
公开(公告)日:2011-01-27
The present invention pertains to complexes comprising sterols and saponins. The complexes are capable of binding a genetic determinant including a polynucleotide. The complexes may further comprise a lipophilic moiety, optionally a lipophilic moiety comprising a contacting group and/or a targeting ligand, and/or a saccharide moiety. The complexes may further comprise an immunogenic determinant and/or an antigenic determinant and/or a medicament and/or a diagnostic compound. The complexes may in even further embodiments be encapsulated by an encapsulation agent including a biodegradable microsphere. The present invention also pertains to pharmaceutical compositions and methods of treatment of an individual by therapy and/or surgery, methods of cosmetic treatment, and diagnostic methods practised on the human or animal body.
POSITIVE ALLOSTERIC MODULATORS OF SWEET TASTE
申请人:Sensorygen, Inc.
公开号:US20180132516A1
公开(公告)日:2018-05-17
The invention provides natural allosteric modulators that are useful as sweet flavor enhancers. The present invention also includes ingestible compositions comprising the present compounds and methods of enhancing the sweet taste of sweeteners and sugars.